SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'MOF'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1A28_A_STRA1_1 (PROGESTERONERECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 10 / 12 | LEU A 563ASN A 564LEU A 566GLN A 570MET A 601ARG A 611MET A 646CYH A 736THR A 739PHE A 749 | MOF A 801 (-3.9A)MOF A 801 (-3.0A)MOF A 801 ( 4.6A)MOF A 801 (-2.9A)MOF A 801 (-3.7A)MOF A 801 (-4.2A)MOF A 801 (-4.4A)MOF A 801 (-3.7A)MOF A 801 (-3.9A)MOF A 801 (-4.4A) | 0.50A | 1a28A-4p6wA:36.3 | 1a28A-4p6wA:54.30 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1A28_B_STRB2_1 (PROGESTERONERECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 9 / 12 | LEU A 563ASN A 564LEU A 566GLN A 570MET A 601ARG A 611MET A 646CYH A 736THR A 739 | MOF A 801 (-3.9A)MOF A 801 (-3.0A)MOF A 801 ( 4.6A)MOF A 801 (-2.9A)MOF A 801 (-3.7A)MOF A 801 (-4.2A)MOF A 801 (-4.4A)MOF A 801 (-3.7A)MOF A 801 (-3.9A) | 0.55A | 1a28B-4p6wA:36.2 | 1a28B-4p6wA:54.30 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1GS4_A_ZK5A1918_1 (ANDROGEN RECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 6 / 12 | ASN A 564GLY A 568GLN A 570TRP A 600MET A 601PHE A 749 | MOF A 801 (-3.0A)NoneMOF A 801 (-2.9A)NoneMOF A 801 (-3.7A)MOF A 801 (-4.4A) | 1.30A | 1gs4A-4p6wA:33.3 | 1gs4A-4p6wA:51.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1GS4_A_ZK5A1918_1 (ANDROGEN RECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 8 / 12 | LEU A 563ASN A 564LEU A 566GLY A 567GLN A 570TRP A 600MET A 601PHE A 749 | MOF A 801 (-3.9A)MOF A 801 (-3.0A)MOF A 801 ( 4.6A)MOF A 801 (-3.4A)MOF A 801 (-2.9A)NoneMOF A 801 (-3.7A)MOF A 801 (-4.4A) | 0.74A | 1gs4A-4p6wA:33.3 | 1gs4A-4p6wA:51.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1M2Z_A_DEXA301_1 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 9 / 12 | ASN A 564GLY A 568GLN A 570TRP A 600MET A 601CYH A 736THR A 739PHE A 749LEU A 753 | MOF A 801 (-3.0A)NoneMOF A 801 (-2.9A)NoneMOF A 801 (-3.7A)MOF A 801 (-3.7A)MOF A 801 (-3.9A)MOF A 801 (-4.4A)None | 0.96A | 1m2zA-4p6wA:38.9 | 1m2zA-4p6wA:97.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1M2Z_A_DEXA301_1 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 12 / 12 | MET A 560ASN A 564GLY A 567GLN A 570TRP A 600MET A 601ARG A 611MET A 646CYH A 736THR A 739PHE A 749LEU A 753 | MOF A 801 (-3.9A)MOF A 801 (-3.0A)MOF A 801 (-3.4A)MOF A 801 (-2.9A)NoneMOF A 801 (-3.7A)MOF A 801 (-4.2A)MOF A 801 (-4.4A)MOF A 801 (-3.7A)MOF A 801 (-3.9A)MOF A 801 (-4.4A)None | 0.42A | 1m2zA-4p6wA:38.9 | 1m2zA-4p6wA:97.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1M2Z_D_DEXD401_1 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 9 / 12 | ASN A 564GLY A 568GLN A 570MET A 601CYH A 736THR A 739ILE A 747PHE A 749LEU A 753 | MOF A 801 (-3.0A)NoneMOF A 801 (-2.9A)MOF A 801 (-3.7A)MOF A 801 (-3.7A)MOF A 801 (-3.9A)MOF A 801 ( 4.4A)MOF A 801 (-4.4A)None | 0.94A | 1m2zD-4p6wA:38.6 | 1m2zD-4p6wA:97.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1M2Z_D_DEXD401_1 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 12 / 12 | MET A 560ASN A 564GLY A 567GLN A 570MET A 601ARG A 611MET A 646CYH A 736THR A 739ILE A 747PHE A 749LEU A 753 | MOF A 801 (-3.9A)MOF A 801 (-3.0A)MOF A 801 (-3.4A)MOF A 801 (-2.9A)MOF A 801 (-3.7A)MOF A 801 (-4.2A)MOF A 801 (-4.4A)MOF A 801 (-3.7A)MOF A 801 (-3.9A)MOF A 801 ( 4.4A)MOF A 801 (-4.4A)None | 0.40A | 1m2zD-4p6wA:38.6 | 1m2zD-4p6wA:97.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1NHZ_A_486A800_1 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 7 / 12 | LEU A 563ASN A 564GLY A 567GLN A 570VAL A 571MET A 604ARG A 611 | MOF A 801 (-3.9A)MOF A 801 (-3.0A)MOF A 801 (-3.4A)MOF A 801 (-2.9A)NoneNoneMOF A 801 (-4.2A) | 1.01A | 1nhzA-4p6wA:31.4 | 1nhzA-4p6wA:96.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1NHZ_A_486A800_1 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 9 / 12 | LEU A 563GLY A 567GLN A 570VAL A 571MET A 604LEU A 608ARG A 611MET A 646LEU A 732 | MOF A 801 (-3.9A)MOF A 801 (-3.4A)MOF A 801 (-2.9A)NoneNoneMOF A 801 ( 4.6A)MOF A 801 (-4.2A)MOF A 801 (-4.4A)MOF A 801 ( 4.2A) | 0.61A | 1nhzA-4p6wA:31.4 | 1nhzA-4p6wA:96.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1NHZ_A_486A800_2 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 4 / 4 | TRP A 600MET A 601PHE A 623TYR A 735 | NoneMOF A 801 (-3.7A)MOF A 801 (-4.7A)MOF A 801 (-4.8A) | 1.16A | 1nhzA-4p6wA:31.4 | 1nhzA-4p6wA:96.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1P93_A_DEXA1999_1 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | ASN A 564GLY A 568MET A 601THR A 739ILE A 747 | MOF A 801 (-3.0A)NoneMOF A 801 (-3.7A)MOF A 801 (-3.9A)MOF A 801 ( 4.4A) | 0.96A | 1p93A-4p6wA:38.0 | 1p93A-4p6wA:96.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1P93_A_DEXA1999_1 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 10 / 12 | LEU A 563ASN A 564LEU A 566GLY A 567GLN A 570MET A 601ARG A 611MET A 646THR A 739ILE A 747 | MOF A 801 (-3.9A)MOF A 801 (-3.0A)MOF A 801 ( 4.6A)MOF A 801 (-3.4A)MOF A 801 (-2.9A)MOF A 801 (-3.7A)MOF A 801 (-4.2A)MOF A 801 (-4.4A)MOF A 801 (-3.9A)MOF A 801 ( 4.4A) | 0.50A | 1p93A-4p6wA:38.0 | 1p93A-4p6wA:96.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1P93_A_DEXA1999_1 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 6 / 12 | MET A 560ASN A 564GLY A 567GLN A 570MET A 601ILE A 747 | MOF A 801 (-3.9A)MOF A 801 (-3.0A)MOF A 801 (-3.4A)MOF A 801 (-2.9A)MOF A 801 (-3.7A)MOF A 801 ( 4.4A) | 0.74A | 1p93A-4p6wA:38.0 | 1p93A-4p6wA:96.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1P93_B_DEXB2999_1 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 11 / 12 | ASN A 564GLY A 567GLN A 570MET A 601LEU A 608ARG A 611MET A 646CYH A 736THR A 739ILE A 747PHE A 749 | MOF A 801 (-3.0A)MOF A 801 (-3.4A)MOF A 801 (-2.9A)MOF A 801 (-3.7A)MOF A 801 ( 4.6A)MOF A 801 (-4.2A)MOF A 801 (-4.4A)MOF A 801 (-3.7A)MOF A 801 (-3.9A)MOF A 801 ( 4.4A)MOF A 801 (-4.4A) | 0.41A | 1p93B-4p6wA:37.8 | 1p93B-4p6wA:96.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1P93_B_DEXB2999_1 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 7 / 12 | ASN A 564GLY A 568MET A 601CYH A 736THR A 739ILE A 747PHE A 749 | MOF A 801 (-3.0A)NoneMOF A 801 (-3.7A)MOF A 801 (-3.7A)MOF A 801 (-3.9A)MOF A 801 ( 4.4A)MOF A 801 (-4.4A) | 0.99A | 1p93B-4p6wA:37.8 | 1p93B-4p6wA:96.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1P93_B_DEXB2999_1 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 7 / 12 | MET A 560ASN A 564GLY A 567MET A 601CYH A 736ILE A 747PHE A 749 | MOF A 801 (-3.9A)MOF A 801 (-3.0A)MOF A 801 (-3.4A)MOF A 801 (-3.7A)MOF A 801 (-3.7A)MOF A 801 ( 4.4A)MOF A 801 (-4.4A) | 0.77A | 1p93B-4p6wA:37.8 | 1p93B-4p6wA:96.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1P93_B_DEXB2999_1 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 6 / 12 | MET A 560ASN A 564LEU A 621CYH A 736ILE A 747PHE A 749 | MOF A 801 (-3.9A)MOF A 801 (-3.0A)NoneMOF A 801 (-3.7A)MOF A 801 ( 4.4A)MOF A 801 (-4.4A) | 1.25A | 1p93B-4p6wA:37.8 | 1p93B-4p6wA:96.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 10 / 12 | ASN A 564GLY A 567GLN A 570MET A 601LEU A 608ARG A 611MET A 646LEU A 732CYH A 736THR A 739 | MOF A 801 (-3.0A)MOF A 801 (-3.4A)MOF A 801 (-2.9A)MOF A 801 (-3.7A)MOF A 801 ( 4.6A)MOF A 801 (-4.2A)MOF A 801 (-4.4A)MOF A 801 ( 4.2A)MOF A 801 (-3.7A)MOF A 801 (-3.9A) | 0.45A | 1p93C-4p6wA:37.4 | 1p93C-4p6wA:96.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | ASN A 564GLY A 568MET A 601CYH A 736THR A 739 | MOF A 801 (-3.0A)NoneMOF A 801 (-3.7A)MOF A 801 (-3.7A)MOF A 801 (-3.9A) | 1.16A | 1p93C-4p6wA:37.4 | 1p93C-4p6wA:96.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 6 / 12 | MET A 560ASN A 564GLY A 567MET A 601LEU A 732CYH A 736 | MOF A 801 (-3.9A)MOF A 801 (-3.0A)MOF A 801 (-3.4A)MOF A 801 (-3.7A)MOF A 801 ( 4.2A)MOF A 801 (-3.7A) | 0.83A | 1p93C-4p6wA:37.4 | 1p93C-4p6wA:96.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 6 / 12 | MET A 601LEU A 608GLN A 642MET A 646LEU A 732CYH A 736 | MOF A 801 (-3.7A)MOF A 801 ( 4.6A)NoneMOF A 801 (-4.4A)MOF A 801 ( 4.2A)MOF A 801 (-3.7A) | 1.04A | 1p93C-4p6wA:37.4 | 1p93C-4p6wA:96.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1P93_D_DEXD4999_1 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 11 / 12 | ASN A 564GLY A 567GLN A 570MET A 601ARG A 611PHE A 623MET A 646CYH A 736THR A 739ILE A 747PHE A 749 | MOF A 801 (-3.0A)MOF A 801 (-3.4A)MOF A 801 (-2.9A)MOF A 801 (-3.7A)MOF A 801 (-4.2A)MOF A 801 (-4.7A)MOF A 801 (-4.4A)MOF A 801 (-3.7A)MOF A 801 (-3.9A)MOF A 801 ( 4.4A)MOF A 801 (-4.4A) | 0.51A | 1p93D-4p6wA:37.6 | 1p93D-4p6wA:96.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1P93_D_DEXD4999_1 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 7 / 12 | ASN A 564GLY A 568MET A 601CYH A 736THR A 739ILE A 747PHE A 749 | MOF A 801 (-3.0A)NoneMOF A 801 (-3.7A)MOF A 801 (-3.7A)MOF A 801 (-3.9A)MOF A 801 ( 4.4A)MOF A 801 (-4.4A) | 1.03A | 1p93D-4p6wA:37.6 | 1p93D-4p6wA:96.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1P93_D_DEXD4999_1 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 9 / 12 | MET A 560ASN A 564GLY A 567GLN A 570MET A 601MET A 646CYH A 736ILE A 747PHE A 749 | MOF A 801 (-3.9A)MOF A 801 (-3.0A)MOF A 801 (-3.4A)MOF A 801 (-2.9A)MOF A 801 (-3.7A)MOF A 801 (-4.4A)MOF A 801 (-3.7A)MOF A 801 ( 4.4A)MOF A 801 (-4.4A) | 0.67A | 1p93D-4p6wA:37.6 | 1p93D-4p6wA:96.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1P93_D_DEXD4999_2 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 4 / 5 | LEU A 563TRP A 600MET A 604LEU A 608 | MOF A 801 (-3.9A)NoneNoneMOF A 801 ( 4.6A) | 0.43A | 1p93D-4p6wA:37.6 | 1p93D-4p6wA:96.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1Q97_B_ADNB486_1 (SR PROTEIN KINASE) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 4 / 4 | VAL A 649ALA A 605LEU A 670PHE A 606 | NoneMOF A 801 ( 4.8A)NoneNone | 1.19A | 1q97B-4p6wA:undetectable | 1q97B-4p6wA:20.05 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1SQN_A_NDRA1001_0 (PROGESTERONERECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 6 / 12 | ASN A 564GLN A 570MET A 601MET A 646TYR A 735CYH A 736 | MOF A 801 (-3.0A)MOF A 801 (-2.9A)MOF A 801 (-3.7A)MOF A 801 (-4.4A)MOF A 801 (-4.8A)MOF A 801 (-3.7A) | 0.67A | 1sqnA-4p6wA:35.8 | 1sqnA-4p6wA:54.47 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1SQN_A_NDRA1001_0 (PROGESTERONERECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 7 / 12 | LEU A 563ASN A 564LEU A 566GLN A 570MET A 601MET A 604MET A 646 | MOF A 801 (-3.9A)MOF A 801 (-3.0A)MOF A 801 ( 4.6A)MOF A 801 (-2.9A)MOF A 801 (-3.7A)NoneMOF A 801 (-4.4A) | 0.90A | 1sqnA-4p6wA:35.8 | 1sqnA-4p6wA:54.47 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1SQN_A_NDRA1001_0 (PROGESTERONERECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 7 / 12 | LEU A 563ASN A 564LEU A 566GLN A 570MET A 601MET A 646CYH A 736 | MOF A 801 (-3.9A)MOF A 801 (-3.0A)MOF A 801 ( 4.6A)MOF A 801 (-2.9A)MOF A 801 (-3.7A)MOF A 801 (-4.4A)MOF A 801 (-3.7A) | 0.66A | 1sqnA-4p6wA:35.8 | 1sqnA-4p6wA:54.47 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1SQN_A_NDRA1001_0 (PROGESTERONERECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | LEU A 566LEU A 563MET A 639LEU A 608MET A 646 | MOF A 801 ( 4.6A)MOF A 801 (-3.9A)MOF A 801 (-3.7A)MOF A 801 ( 4.6A)MOF A 801 (-4.4A) | 1.31A | 1sqnA-4p6wA:35.8 | 1sqnA-4p6wA:54.47 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1SQN_B_NDRB2001_0 (PROGESTERONERECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 7 / 12 | ASN A 564GLN A 570MET A 601MET A 646LEU A 732TYR A 735CYH A 736 | MOF A 801 (-3.0A)MOF A 801 (-2.9A)MOF A 801 (-3.7A)MOF A 801 (-4.4A)MOF A 801 ( 4.2A)MOF A 801 (-4.8A)MOF A 801 (-3.7A) | 0.51A | 1sqnB-4p6wA:36.1 | 1sqnB-4p6wA:54.47 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1SQN_B_NDRB2001_0 (PROGESTERONERECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 8 / 12 | LEU A 563ASN A 564LEU A 566GLN A 570MET A 601MET A 646LEU A 732CYH A 736 | MOF A 801 (-3.9A)MOF A 801 (-3.0A)MOF A 801 ( 4.6A)MOF A 801 (-2.9A)MOF A 801 (-3.7A)MOF A 801 (-4.4A)MOF A 801 ( 4.2A)MOF A 801 (-3.7A) | 0.57A | 1sqnB-4p6wA:36.1 | 1sqnB-4p6wA:54.47 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1SQN_B_NDRB2001_0 (PROGESTERONERECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 7 / 12 | LEU A 563LEU A 566GLN A 570MET A 601MET A 604MET A 646LEU A 732 | MOF A 801 (-3.9A)MOF A 801 ( 4.6A)MOF A 801 (-2.9A)MOF A 801 (-3.7A)NoneMOF A 801 (-4.4A)MOF A 801 ( 4.2A) | 0.85A | 1sqnB-4p6wA:36.1 | 1sqnB-4p6wA:54.47 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1SQN_B_NDRB2001_0 (PROGESTERONERECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 6 / 12 | LEU A 566LEU A 563MET A 639LEU A 608MET A 646LEU A 621 | MOF A 801 ( 4.6A)MOF A 801 (-3.9A)MOF A 801 (-3.7A)MOF A 801 ( 4.6A)MOF A 801 (-4.4A)None | 1.28A | 1sqnB-4p6wA:36.1 | 1sqnB-4p6wA:54.47 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1YA3_A_STRA1001_1 (MINERALOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 9 / 12 | ASN A 564LEU A 566GLN A 570MET A 601LEU A 608ARG A 611MET A 646CYH A 736THR A 739 | MOF A 801 (-3.0A)MOF A 801 ( 4.6A)MOF A 801 (-2.9A)MOF A 801 (-3.7A)MOF A 801 ( 4.6A)MOF A 801 (-4.2A)MOF A 801 (-4.4A)MOF A 801 (-3.7A)MOF A 801 (-3.9A) | 0.66A | 1ya3A-4p6wA:33.9 | 1ya3A-4p6wA:56.47 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1YA3_B_STRB2001_1 (MINERALOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 8 / 12 | ASN A 564GLN A 570MET A 601LEU A 608ARG A 611LEU A 732CYH A 736THR A 739 | MOF A 801 (-3.0A)MOF A 801 (-2.9A)MOF A 801 (-3.7A)MOF A 801 ( 4.6A)MOF A 801 (-4.2A)MOF A 801 ( 4.2A)MOF A 801 (-3.7A)MOF A 801 (-3.9A) | 0.39A | 1ya3B-4p6wA:33.5 | 1ya3B-4p6wA:56.47 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1YA3_B_STRB2001_1 (MINERALOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | ASN A 564LEU A 621LEU A 732CYH A 736THR A 739 | MOF A 801 (-3.0A)NoneMOF A 801 ( 4.2A)MOF A 801 (-3.7A)MOF A 801 (-3.9A) | 1.35A | 1ya3B-4p6wA:33.5 | 1ya3B-4p6wA:56.47 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1YA3_C_STRC3001_1 (MINERALOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 9 / 12 | LEU A 563ASN A 564LEU A 566GLN A 570MET A 601ARG A 611LEU A 732CYH A 736THR A 739 | MOF A 801 (-3.9A)MOF A 801 (-3.0A)MOF A 801 ( 4.6A)MOF A 801 (-2.9A)MOF A 801 (-3.7A)MOF A 801 (-4.2A)MOF A 801 ( 4.2A)MOF A 801 (-3.7A)MOF A 801 (-3.9A) | 0.44A | 1ya3C-4p6wA:33.5 | 1ya3C-4p6wA:56.47 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1Z95_A_198A501_1 (ANDROGEN RECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | GLY A 568GLN A 570MET A 604ARG A 611ILE A 757 | NoneMOF A 801 (-2.9A)NoneMOF A 801 (-4.2A)None | 1.22A | 1z95A-4p6wA:32.4 | 1z95A-4p6wA:50.60 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1Z95_A_198A501_1 (ANDROGEN RECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 7 / 12 | LEU A 566GLY A 567GLN A 570MET A 601MET A 604ARG A 611ILE A 757 | MOF A 801 ( 4.6A)MOF A 801 (-3.4A)MOF A 801 (-2.9A)MOF A 801 (-3.7A)NoneMOF A 801 (-4.2A)None | 0.85A | 1z95A-4p6wA:32.4 | 1z95A-4p6wA:50.60 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1ZUC_A_T98A201_1 (PROGESTERONERECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 7 / 10 | ASN A 564GLN A 570LEU A 608ARG A 611TYR A 735THR A 739PHE A 749 | MOF A 801 (-3.0A)MOF A 801 (-2.9A)MOF A 801 ( 4.6A)MOF A 801 (-4.2A)MOF A 801 (-4.8A)MOF A 801 (-3.9A)MOF A 801 (-4.4A) | 0.58A | 1zucA-4p6wA:36.2 | 1zucA-4p6wA:54.47 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1ZUC_A_T98A201_1 (PROGESTERONERECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 5 / 10 | ASN A 564LEU A 621TYR A 735THR A 739PHE A 749 | MOF A 801 (-3.0A)NoneMOF A 801 (-4.8A)MOF A 801 (-3.9A)MOF A 801 (-4.4A) | 0.98A | 1zucA-4p6wA:36.2 | 1zucA-4p6wA:54.47 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1ZUC_B_T98B202_1 (PROGESTERONERECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 8 / 12 | ASN A 564LEU A 566GLN A 570MET A 601LEU A 608ARG A 611THR A 739PHE A 749 | MOF A 801 (-3.0A)MOF A 801 ( 4.6A)MOF A 801 (-2.9A)MOF A 801 (-3.7A)MOF A 801 ( 4.6A)MOF A 801 (-4.2A)MOF A 801 (-3.9A)MOF A 801 (-4.4A) | 0.62A | 1zucB-4p6wA:35.9 | 1zucB-4p6wA:54.47 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1ZUC_B_T98B202_1 (PROGESTERONERECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 8 / 12 | LEU A 563ASN A 564LEU A 566GLN A 570LEU A 608ARG A 611THR A 739PHE A 749 | MOF A 801 (-3.9A)MOF A 801 (-3.0A)MOF A 801 ( 4.6A)MOF A 801 (-2.9A)MOF A 801 ( 4.6A)MOF A 801 (-4.2A)MOF A 801 (-3.9A)MOF A 801 (-4.4A) | 0.78A | 1zucB-4p6wA:35.9 | 1zucB-4p6wA:54.47 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1ZUC_B_T98B202_1 (PROGESTERONERECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | LEU A 566GLN A 570MET A 604LEU A 608ARG A 611 | MOF A 801 ( 4.6A)MOF A 801 (-2.9A)NoneMOF A 801 ( 4.6A)MOF A 801 (-4.2A) | 0.92A | 1zucB-4p6wA:35.9 | 1zucB-4p6wA:54.47 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AA5_A_STRA301_1 (MINERALOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 9 / 12 | ASN A 564LEU A 566GLN A 570MET A 601LEU A 608ARG A 611MET A 646CYH A 736THR A 739 | MOF A 801 (-3.0A)MOF A 801 ( 4.6A)MOF A 801 (-2.9A)MOF A 801 (-3.7A)MOF A 801 ( 4.6A)MOF A 801 (-4.2A)MOF A 801 (-4.4A)MOF A 801 (-3.7A)MOF A 801 (-3.9A) | 0.73A | 2aa5A-4p6wA:34.4 | 2aa5A-4p6wA:56.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AA5_B_STRB302_1 (MINERALOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 8 / 12 | ASN A 564LEU A 566GLN A 570MET A 601LEU A 608ARG A 611CYH A 736THR A 739 | MOF A 801 (-3.0A)MOF A 801 ( 4.6A)MOF A 801 (-2.9A)MOF A 801 (-3.7A)MOF A 801 ( 4.6A)MOF A 801 (-4.2A)MOF A 801 (-3.7A)MOF A 801 (-3.9A) | 0.45A | 2aa5B-4p6wA:34.7 | 2aa5B-4p6wA:56.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AA6_A_STRA401_1 (MINERALOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 10 / 12 | LEU A 563ASN A 564LEU A 566GLN A 570MET A 601LEU A 608ARG A 611MET A 646CYH A 736THR A 739 | MOF A 801 (-3.9A)MOF A 801 (-3.0A)MOF A 801 ( 4.6A)MOF A 801 (-2.9A)MOF A 801 (-3.7A)MOF A 801 ( 4.6A)MOF A 801 (-4.2A)MOF A 801 (-4.4A)MOF A 801 (-3.7A)MOF A 801 (-3.9A) | 0.74A | 2aa6A-4p6wA:34.5 | 2aa6A-4p6wA:56.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AA6_B_STRB402_1 (MINERALOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 10 / 12 | ASN A 564LEU A 566GLN A 570MET A 601LEU A 608ARG A 611MET A 646LEU A 732CYH A 736THR A 739 | MOF A 801 (-3.0A)MOF A 801 ( 4.6A)MOF A 801 (-2.9A)MOF A 801 (-3.7A)MOF A 801 ( 4.6A)MOF A 801 (-4.2A)MOF A 801 (-4.4A)MOF A 801 ( 4.2A)MOF A 801 (-3.7A)MOF A 801 (-3.9A) | 0.72A | 2aa6B-4p6wA:34.6 | 2aa6B-4p6wA:56.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AB2_A_SNLA502_1 (MINERALOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 9 / 12 | ASN A 564GLN A 570MET A 601ARG A 611PHE A 623MET A 646CYH A 736THR A 739PHE A 749 | MOF A 801 (-3.0A)MOF A 801 (-2.9A)MOF A 801 (-3.7A)MOF A 801 (-4.2A)MOF A 801 (-4.7A)MOF A 801 (-4.4A)MOF A 801 (-3.7A)MOF A 801 (-3.9A)MOF A 801 (-4.4A) | 0.72A | 2ab2A-4p6wA:34.4 | 2ab2A-4p6wA:56.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AB2_A_SNLA502_2 (MINERALOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 5 / 6 | LEU A 563LEU A 566LEU A 608CYH A 643LEU A 732 | MOF A 801 (-3.9A)MOF A 801 ( 4.6A)MOF A 801 ( 4.6A)MOF A 801 ( 3.7A)MOF A 801 ( 4.2A) | 0.65A | 2ab2A-4p6wA:34.4 | 2ab2A-4p6wA:56.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AB2_B_SNLB503_1 (MINERALOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 8 / 12 | ASN A 564GLN A 570MET A 601ARG A 611PHE A 623CYH A 736THR A 739PHE A 749 | MOF A 801 (-3.0A)MOF A 801 (-2.9A)MOF A 801 (-3.7A)MOF A 801 (-4.2A)MOF A 801 (-4.7A)MOF A 801 (-3.7A)MOF A 801 (-3.9A)MOF A 801 (-4.4A) | 0.32A | 2ab2B-4p6wA:34.5 | 2ab2B-4p6wA:56.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AB2_B_SNLB503_1 (MINERALOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 7 / 12 | ASN A 564GLN A 570MET A 601ARG A 611PHE A 623MET A 646CYH A 736 | MOF A 801 (-3.0A)MOF A 801 (-2.9A)MOF A 801 (-3.7A)MOF A 801 (-4.2A)MOF A 801 (-4.7A)MOF A 801 (-4.4A)MOF A 801 (-3.7A) | 0.75A | 2ab2B-4p6wA:34.5 | 2ab2B-4p6wA:56.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AB2_B_SNLB503_2 (MINERALOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 4 / 5 | LEU A 563LEU A 566LEU A 608CYH A 643 | MOF A 801 (-3.9A)MOF A 801 ( 4.6A)MOF A 801 ( 4.6A)MOF A 801 ( 3.7A) | 0.65A | 2ab2B-4p6wA:34.5 | 2ab2B-4p6wA:56.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AM9_A_TESA1000_1 (ANDROGEN RECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 6 / 12 | ASN A 564LEU A 566TRP A 600MET A 601MET A 604ARG A 611 | MOF A 801 (-3.0A)MOF A 801 ( 4.6A)NoneMOF A 801 (-3.7A)NoneMOF A 801 (-4.2A) | 0.80A | 2am9A-4p6wA:33.5 | 2am9A-4p6wA:48.87 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AM9_A_TESA1000_1 (ANDROGEN RECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 6 / 12 | ASN A 564TRP A 600MET A 601MET A 604ARG A 611LEU A 732 | MOF A 801 (-3.0A)NoneMOF A 801 (-3.7A)NoneMOF A 801 (-4.2A)MOF A 801 ( 4.2A) | 0.74A | 2am9A-4p6wA:33.5 | 2am9A-4p6wA:48.87 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AM9_A_TESA1000_1 (ANDROGEN RECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 6 / 12 | GLN A 570TRP A 600MET A 601MET A 604ARG A 611LEU A 732 | MOF A 801 (-2.9A)NoneMOF A 801 (-3.7A)NoneMOF A 801 (-4.2A)MOF A 801 ( 4.2A) | 0.95A | 2am9A-4p6wA:33.5 | 2am9A-4p6wA:48.87 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AM9_A_TESA1000_1 (ANDROGEN RECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 6 / 12 | LEU A 566GLN A 570TRP A 600MET A 601MET A 604ARG A 611 | MOF A 801 ( 4.6A)MOF A 801 (-2.9A)NoneMOF A 801 (-3.7A)NoneMOF A 801 (-4.2A) | 1.07A | 2am9A-4p6wA:33.5 | 2am9A-4p6wA:48.87 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OAX_A_SNLA1001_1 (MINERALOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 10 / 12 | ASN A 564LEU A 566GLN A 570MET A 601LEU A 608ARG A 611LEU A 732CYH A 736THR A 739PHE A 749 | MOF A 801 (-3.0A)MOF A 801 ( 4.6A)MOF A 801 (-2.9A)MOF A 801 (-3.7A)MOF A 801 ( 4.6A)MOF A 801 (-4.2A)MOF A 801 ( 4.2A)MOF A 801 (-3.7A)MOF A 801 (-3.9A)MOF A 801 (-4.4A) | 0.54A | 2oaxA-4p6wA:33.6 | 2oaxA-4p6wA:56.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OAX_A_SNLA1001_1 (MINERALOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 6 / 12 | ASN A 564LEU A 621LEU A 732CYH A 736THR A 739PHE A 749 | MOF A 801 (-3.0A)NoneMOF A 801 ( 4.2A)MOF A 801 (-3.7A)MOF A 801 (-3.9A)MOF A 801 (-4.4A) | 1.24A | 2oaxA-4p6wA:33.6 | 2oaxA-4p6wA:56.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OAX_B_SNLB2001_1 (MINERALOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 10 / 12 | ASN A 564LEU A 566GLN A 570MET A 601LEU A 608ARG A 611LEU A 732CYH A 736THR A 739PHE A 749 | MOF A 801 (-3.0A)MOF A 801 ( 4.6A)MOF A 801 (-2.9A)MOF A 801 (-3.7A)MOF A 801 ( 4.6A)MOF A 801 (-4.2A)MOF A 801 ( 4.2A)MOF A 801 (-3.7A)MOF A 801 (-3.9A)MOF A 801 (-4.4A) | 0.42A | 2oaxB-4p6wA:33.4 | 2oaxB-4p6wA:56.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OAX_B_SNLB2001_1 (MINERALOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | ASN A 564LEU A 621CYH A 736THR A 739PHE A 749 | MOF A 801 (-3.0A)NoneMOF A 801 (-3.7A)MOF A 801 (-3.9A)MOF A 801 (-4.4A) | 1.10A | 2oaxB-4p6wA:33.4 | 2oaxB-4p6wA:56.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OAX_C_SNLC3001_1 (MINERALOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 9 / 12 | ASN A 564GLN A 570TRP A 600MET A 601LEU A 608ARG A 611LEU A 732THR A 739PHE A 749 | MOF A 801 (-3.0A)MOF A 801 (-2.9A)NoneMOF A 801 (-3.7A)MOF A 801 ( 4.6A)MOF A 801 (-4.2A)MOF A 801 ( 4.2A)MOF A 801 (-3.9A)MOF A 801 (-4.4A) | 0.41A | 2oaxC-4p6wA:32.5 | 2oaxC-4p6wA:56.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OAX_C_SNLC3001_1 (MINERALOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | ASN A 564LEU A 621LEU A 732THR A 739PHE A 749 | MOF A 801 (-3.0A)NoneMOF A 801 ( 4.2A)MOF A 801 (-3.9A)MOF A 801 (-4.4A) | 1.34A | 2oaxC-4p6wA:32.5 | 2oaxC-4p6wA:56.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OAX_D_SNLD4001_1 (MINERALOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 9 / 12 | ASN A 564LEU A 566GLN A 570TRP A 600MET A 601LEU A 608ARG A 611LEU A 732PHE A 749 | MOF A 801 (-3.0A)MOF A 801 ( 4.6A)MOF A 801 (-2.9A)NoneMOF A 801 (-3.7A)MOF A 801 ( 4.6A)MOF A 801 (-4.2A)MOF A 801 ( 4.2A)MOF A 801 (-4.4A) | 0.48A | 2oaxD-4p6wA:34.1 | 2oaxD-4p6wA:56.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OAX_E_SNLE5001_1 (MINERALOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 9 / 12 | ASN A 564LEU A 566GLN A 570MET A 601LEU A 608ARG A 611LEU A 732CYH A 736PHE A 749 | MOF A 801 (-3.0A)MOF A 801 ( 4.6A)MOF A 801 (-2.9A)MOF A 801 (-3.7A)MOF A 801 ( 4.6A)MOF A 801 (-4.2A)MOF A 801 ( 4.2A)MOF A 801 (-3.7A)MOF A 801 (-4.4A) | 0.57A | 2oaxE-4p6wA:34.0 | 2oaxE-4p6wA:56.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OAX_E_SNLE5001_1 (MINERALOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | ASN A 564LEU A 621LEU A 732CYH A 736PHE A 749 | MOF A 801 (-3.0A)NoneMOF A 801 ( 4.2A)MOF A 801 (-3.7A)MOF A 801 (-4.4A) | 1.17A | 2oaxE-4p6wA:34.0 | 2oaxE-4p6wA:56.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OAX_F_SNLF6001_1 (MINERALOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 11 / 12 | ASN A 564LEU A 566GLN A 570TRP A 600MET A 601LEU A 608ARG A 611LEU A 732CYH A 736THR A 739PHE A 749 | MOF A 801 (-3.0A)MOF A 801 ( 4.6A)MOF A 801 (-2.9A)NoneMOF A 801 (-3.7A)MOF A 801 ( 4.6A)MOF A 801 (-4.2A)MOF A 801 ( 4.2A)MOF A 801 (-3.7A)MOF A 801 (-3.9A)MOF A 801 (-4.4A) | 0.49A | 2oaxF-4p6wA:34.1 | 2oaxF-4p6wA:56.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OAX_F_SNLF6001_1 (MINERALOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | ASN A 564LEU A 621CYH A 736THR A 739PHE A 749 | MOF A 801 (-3.0A)NoneMOF A 801 (-3.7A)MOF A 801 (-3.9A)MOF A 801 (-4.4A) | 1.07A | 2oaxF-4p6wA:34.1 | 2oaxF-4p6wA:56.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OZ7_A_CA4A1_1 (ANDROGEN RECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 7 / 12 | LEU A 563ASN A 564LEU A 566GLY A 567GLN A 570ARG A 611PHE A 749 | MOF A 801 (-3.9A)MOF A 801 (-3.0A)MOF A 801 ( 4.6A)MOF A 801 (-3.4A)MOF A 801 (-2.9A)MOF A 801 (-4.2A)MOF A 801 (-4.4A) | 0.78A | 2oz7A-4p6wA:32.2 | 2oz7A-4p6wA:50.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2Q7I_A_TESA205_1 (ANDROGEN RECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 7 / 12 | LEU A 563ASN A 564LEU A 566GLN A 570MET A 601MET A 604ARG A 611 | MOF A 801 (-3.9A)MOF A 801 (-3.0A)MOF A 801 ( 4.6A)MOF A 801 (-2.9A)MOF A 801 (-3.7A)NoneMOF A 801 (-4.2A) | 0.91A | 2q7iA-4p6wA:33.0 | 2q7iA-4p6wA:49.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2Q7J_A_TESA203_1 (ANDROGEN RECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 7 / 12 | ASN A 564LEU A 566GLN A 570TRP A 600MET A 601MET A 604ARG A 611 | MOF A 801 (-3.0A)MOF A 801 ( 4.6A)MOF A 801 (-2.9A)NoneMOF A 801 (-3.7A)NoneMOF A 801 (-4.2A) | 0.84A | 2q7jA-4p6wA:33.5 | 2q7jA-4p6wA:49.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2Q7K_A_TESA304_1 (ANDROGEN RECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 6 / 12 | ASN A 564LEU A 566GLN A 570MET A 601ARG A 611LEU A 732 | MOF A 801 (-3.0A)MOF A 801 ( 4.6A)MOF A 801 (-2.9A)MOF A 801 (-3.7A)MOF A 801 (-4.2A)MOF A 801 ( 4.2A) | 0.78A | 2q7kA-4p6wA:33.2 | 2q7kA-4p6wA:50.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2Q7K_A_TESA304_1 (ANDROGEN RECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 6 / 12 | LEU A 563ASN A 564LEU A 566GLN A 570MET A 601ARG A 611 | MOF A 801 (-3.9A)MOF A 801 (-3.0A)MOF A 801 ( 4.6A)MOF A 801 (-2.9A)MOF A 801 (-3.7A)MOF A 801 (-4.2A) | 0.83A | 2q7kA-4p6wA:33.2 | 2q7kA-4p6wA:50.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2Q7L_A_TESA155_1 (ANDROGEN RECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 8 / 12 | LEU A 563ASN A 564LEU A 566GLY A 567GLN A 570TRP A 600MET A 601ARG A 611 | MOF A 801 (-3.9A)MOF A 801 (-3.0A)MOF A 801 ( 4.6A)MOF A 801 (-3.4A)MOF A 801 (-2.9A)NoneMOF A 801 (-3.7A)MOF A 801 (-4.2A) | 0.79A | 2q7lA-4p6wA:33.4 | 2q7lA-4p6wA:50.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2W8Y_A_486A1000_1 (PROGESTERONERECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | GLY A 568GLN A 570TRP A 600MET A 601CYH A 736 | NoneMOF A 801 (-2.9A)NoneMOF A 801 (-3.7A)MOF A 801 (-3.7A) | 1.12A | 2w8yA-4p6wA:36.2 | 2w8yA-4p6wA:53.46 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2W8Y_A_486A1000_1 (PROGESTERONERECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 7 / 12 | LEU A 566GLY A 567GLN A 570TRP A 600MET A 601ARG A 611CYH A 736 | MOF A 801 ( 4.6A)MOF A 801 (-3.4A)MOF A 801 (-2.9A)NoneMOF A 801 (-3.7A)MOF A 801 (-4.2A)MOF A 801 (-3.7A) | 0.48A | 2w8yA-4p6wA:36.2 | 2w8yA-4p6wA:53.46 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2W8Y_A_486A1000_1 (PROGESTERONERECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 7 / 12 | LEU A 566GLY A 567GLN A 570TRP A 600MET A 601MET A 604ARG A 611 | MOF A 801 ( 4.6A)MOF A 801 (-3.4A)MOF A 801 (-2.9A)NoneMOF A 801 (-3.7A)NoneMOF A 801 (-4.2A) | 0.78A | 2w8yA-4p6wA:36.2 | 2w8yA-4p6wA:53.46 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2W8Y_B_NDRB1000_0 (PROGESTERONERECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 7 / 12 | ASN A 564GLN A 570MET A 601ARG A 611MET A 646TYR A 735CYH A 736 | MOF A 801 (-3.0A)MOF A 801 (-2.9A)MOF A 801 (-3.7A)MOF A 801 (-4.2A)MOF A 801 (-4.4A)MOF A 801 (-4.8A)MOF A 801 (-3.7A) | 0.66A | 2w8yB-4p6wA:36.2 | 2w8yB-4p6wA:53.46 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2W8Y_B_NDRB1000_0 (PROGESTERONERECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 8 / 12 | LEU A 563ASN A 564LEU A 566GLN A 570MET A 601ARG A 611MET A 646CYH A 736 | MOF A 801 (-3.9A)MOF A 801 (-3.0A)MOF A 801 ( 4.6A)MOF A 801 (-2.9A)MOF A 801 (-3.7A)MOF A 801 (-4.2A)MOF A 801 (-4.4A)MOF A 801 (-3.7A) | 0.64A | 2w8yB-4p6wA:36.2 | 2w8yB-4p6wA:53.46 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2W8Y_B_NDRB1000_0 (PROGESTERONERECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 8 / 12 | LEU A 563ASN A 564LEU A 566GLN A 570MET A 601MET A 604ARG A 611MET A 646 | MOF A 801 (-3.9A)MOF A 801 (-3.0A)MOF A 801 ( 4.6A)MOF A 801 (-2.9A)MOF A 801 (-3.7A)NoneMOF A 801 (-4.2A)MOF A 801 (-4.4A) | 0.86A | 2w8yB-4p6wA:36.2 | 2w8yB-4p6wA:53.46 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2W8Y_B_NDRB1000_0 (PROGESTERONERECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | LEU A 566LEU A 563MET A 639LEU A 608MET A 646 | MOF A 801 ( 4.6A)MOF A 801 (-3.9A)MOF A 801 (-3.7A)MOF A 801 ( 4.6A)MOF A 801 (-4.4A) | 1.29A | 2w8yB-4p6wA:36.2 | 2w8yB-4p6wA:53.46 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2YHD_A_TESA1920_1 (ANDROGEN RECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 7 / 12 | ASN A 564LEU A 566GLY A 567GLN A 570MET A 601MET A 604ARG A 611 | MOF A 801 (-3.0A)MOF A 801 ( 4.6A)MOF A 801 (-3.4A)MOF A 801 (-2.9A)MOF A 801 (-3.7A)NoneMOF A 801 (-4.2A) | 0.78A | 2yhdA-4p6wA:33.1 | 2yhdA-4p6wA:50.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2YLO_A_TESA1920_1 (ANDROGEN RECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 7 / 12 | LEU A 563ASN A 564LEU A 566MET A 601MET A 604ARG A 611PHE A 749 | MOF A 801 (-3.9A)MOF A 801 (-3.0A)MOF A 801 ( 4.6A)MOF A 801 (-3.7A)NoneMOF A 801 (-4.2A)MOF A 801 (-4.4A) | 0.93A | 2yloA-4p6wA:33.2 | 2yloA-4p6wA:49.61 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2YLO_A_TESA1920_1 (ANDROGEN RECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | LEU A 566GLN A 570MET A 601MET A 604ARG A 611 | MOF A 801 ( 4.6A)MOF A 801 (-2.9A)MOF A 801 (-3.7A)NoneMOF A 801 (-4.2A) | 1.06A | 2yloA-4p6wA:33.2 | 2yloA-4p6wA:49.61 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2YLP_A_TESA1921_1 (ANDROGEN RECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 7 / 11 | ASN A 564LEU A 566GLN A 570MET A 601MET A 604ARG A 611LEU A 732 | MOF A 801 (-3.0A)MOF A 801 ( 4.6A)MOF A 801 (-2.9A)MOF A 801 (-3.7A)NoneMOF A 801 (-4.2A)MOF A 801 ( 4.2A) | 0.88A | 2ylpA-4p6wA:33.4 | 2ylpA-4p6wA:49.61 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2YLQ_A_TESA1921_1 (ANDROGEN RECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 6 / 11 | ASN A 564LEU A 566GLN A 570MET A 601MET A 604ARG A 611 | MOF A 801 (-3.0A)MOF A 801 ( 4.6A)MOF A 801 (-2.9A)MOF A 801 (-3.7A)NoneMOF A 801 (-4.2A) | 0.83A | 2ylqA-4p6wA:33.4 | 2ylqA-4p6wA:49.61 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CLD_A_GW6A1_1 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | ASN A 564GLY A 567LEU A 627THR A 739PHE A 749 | MOF A 801 (-3.0A)MOF A 801 (-3.4A)NoneMOF A 801 (-3.9A)MOF A 801 (-4.4A) | 1.47A | 3cldA-4p6wA:39.3 | 3cldA-4p6wA:96.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CLD_A_GW6A1_1 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 7 / 12 | ASN A 564GLY A 568GLN A 570MET A 601CYH A 736THR A 739PHE A 749 | MOF A 801 (-3.0A)NoneMOF A 801 (-2.9A)MOF A 801 (-3.7A)MOF A 801 (-3.7A)MOF A 801 (-3.9A)MOF A 801 (-4.4A) | 1.06A | 3cldA-4p6wA:39.3 | 3cldA-4p6wA:96.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CLD_A_GW6A1_1 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 12 / 12 | MET A 560ASN A 564GLY A 567GLN A 570MET A 601LEU A 608ARG A 611CYH A 643LEU A 732CYH A 736THR A 739PHE A 749 | MOF A 801 (-3.9A)MOF A 801 (-3.0A)MOF A 801 (-3.4A)MOF A 801 (-2.9A)MOF A 801 (-3.7A)MOF A 801 ( 4.6A)MOF A 801 (-4.2A)MOF A 801 ( 3.7A)MOF A 801 ( 4.2A)MOF A 801 (-3.7A)MOF A 801 (-3.9A)MOF A 801 (-4.4A) | 0.29A | 3cldA-4p6wA:39.3 | 3cldA-4p6wA:96.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CLD_A_GW6A1_1 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 6 / 12 | MET A 560ASN A 564LEU A 621CYH A 736THR A 739PHE A 749 | MOF A 801 (-3.9A)MOF A 801 (-3.0A)NoneMOF A 801 (-3.7A)MOF A 801 (-3.9A)MOF A 801 (-4.4A) | 1.30A | 3cldA-4p6wA:39.3 | 3cldA-4p6wA:96.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CLD_A_GW6A1_2 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 9 / 9 | LEU A 563LEU A 566TRP A 600MET A 604ALA A 605MET A 639GLN A 642MET A 646TYR A 735 | MOF A 801 (-3.9A)MOF A 801 ( 4.6A)NoneNoneMOF A 801 ( 4.8A)MOF A 801 (-3.7A)NoneMOF A 801 (-4.4A)MOF A 801 (-4.8A) | 0.58A | 3cldA-4p6wA:39.3 | 3cldA-4p6wA:96.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CLD_B_GW6B2_1 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 6 / 12 | ASN A 564GLY A 568MET A 601CYH A 736THR A 739PHE A 749 | MOF A 801 (-3.0A)NoneMOF A 801 (-3.7A)MOF A 801 (-3.7A)MOF A 801 (-3.9A)MOF A 801 (-4.4A) | 0.91A | 3cldB-4p6wA:39.2 | 3cldB-4p6wA:96.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CLD_B_GW6B2_1 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 12 / 12 | MET A 560ASN A 564GLY A 567GLN A 570MET A 601ARG A 611MET A 639CYH A 643LEU A 732CYH A 736THR A 739PHE A 749 | MOF A 801 (-3.9A)MOF A 801 (-3.0A)MOF A 801 (-3.4A)MOF A 801 (-2.9A)MOF A 801 (-3.7A)MOF A 801 (-4.2A)MOF A 801 (-3.7A)MOF A 801 ( 3.7A)MOF A 801 ( 4.2A)MOF A 801 (-3.7A)MOF A 801 (-3.9A)MOF A 801 (-4.4A) | 0.46A | 3cldB-4p6wA:39.2 | 3cldB-4p6wA:96.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CLD_B_GW6B2_2 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 8 / 8 | LEU A 563MET A 604ALA A 605LEU A 608GLN A 642MET A 646TYR A 735ILE A 747 | MOF A 801 (-3.9A)NoneMOF A 801 ( 4.8A)MOF A 801 ( 4.6A)NoneMOF A 801 (-4.4A)MOF A 801 (-4.8A)MOF A 801 ( 4.4A) | 0.55A | 3cldB-4p6wA:39.2 | 3cldB-4p6wA:96.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3D90_A_NOGA1001_1 (PROGESTERONERECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 7 / 12 | ASN A 564GLN A 570MET A 601ARG A 611MET A 646TYR A 735CYH A 736 | MOF A 801 (-3.0A)MOF A 801 (-2.9A)MOF A 801 (-3.7A)MOF A 801 (-4.2A)MOF A 801 (-4.4A)MOF A 801 (-4.8A)MOF A 801 (-3.7A) | 0.72A | 3d90A-4p6wA:35.4 | 3d90A-4p6wA:54.47 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3D90_A_NOGA1001_1 (PROGESTERONERECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 8 / 12 | LEU A 563ASN A 564LEU A 566GLN A 570MET A 601ARG A 611MET A 646CYH A 736 | MOF A 801 (-3.9A)MOF A 801 (-3.0A)MOF A 801 ( 4.6A)MOF A 801 (-2.9A)MOF A 801 (-3.7A)MOF A 801 (-4.2A)MOF A 801 (-4.4A)MOF A 801 (-3.7A) | 0.68A | 3d90A-4p6wA:35.4 | 3d90A-4p6wA:54.47 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3D90_A_NOGA1001_1 (PROGESTERONERECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 8 / 12 | LEU A 563ASN A 564LEU A 566GLN A 570MET A 601MET A 604ARG A 611MET A 646 | MOF A 801 (-3.9A)MOF A 801 (-3.0A)MOF A 801 ( 4.6A)MOF A 801 (-2.9A)MOF A 801 (-3.7A)NoneMOF A 801 (-4.2A)MOF A 801 (-4.4A) | 0.94A | 3d90A-4p6wA:35.4 | 3d90A-4p6wA:54.47 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3D90_A_NOGA1001_1 (PROGESTERONERECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | LEU A 566LEU A 563MET A 639LEU A 608MET A 646 | MOF A 801 ( 4.6A)MOF A 801 (-3.9A)MOF A 801 (-3.7A)MOF A 801 ( 4.6A)MOF A 801 (-4.4A) | 1.32A | 3d90A-4p6wA:35.4 | 3d90A-4p6wA:54.47 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3D90_B_NOGB2001_1 (PROGESTERONERECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 9 / 12 | ASN A 564LEU A 566GLN A 570MET A 601LEU A 608ARG A 611MET A 646TYR A 735CYH A 736 | MOF A 801 (-3.0A)MOF A 801 ( 4.6A)MOF A 801 (-2.9A)MOF A 801 (-3.7A)MOF A 801 ( 4.6A)MOF A 801 (-4.2A)MOF A 801 (-4.4A)MOF A 801 (-4.8A)MOF A 801 (-3.7A) | 0.63A | 3d90B-4p6wA:35.7 | 3d90B-4p6wA:54.47 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3D90_B_NOGB2001_1 (PROGESTERONERECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 9 / 12 | LEU A 563ASN A 564LEU A 566GLN A 570MET A 601LEU A 608ARG A 611MET A 646CYH A 736 | MOF A 801 (-3.9A)MOF A 801 (-3.0A)MOF A 801 ( 4.6A)MOF A 801 (-2.9A)MOF A 801 (-3.7A)MOF A 801 ( 4.6A)MOF A 801 (-4.2A)MOF A 801 (-4.4A)MOF A 801 (-3.7A) | 0.65A | 3d90B-4p6wA:35.7 | 3d90B-4p6wA:54.47 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3GN8_A_DEXA247_1 (GLUCOCORTICOIDRECEPTOR 2) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 6 / 12 | ASN A 564GLY A 568TRP A 600MET A 601CYH A 736THR A 739 | MOF A 801 (-3.0A)NoneNoneMOF A 801 (-3.7A)MOF A 801 (-3.7A)MOF A 801 (-3.9A) | 0.97A | 3gn8A-4p6wA:38.8 | 3gn8A-4p6wA:76.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3GN8_A_DEXA247_1 (GLUCOCORTICOIDRECEPTOR 2) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 10 / 12 | LEU A 563ASN A 564GLY A 567GLN A 570TRP A 600MET A 601ARG A 611MET A 646CYH A 736THR A 739 | MOF A 801 (-3.9A)MOF A 801 (-3.0A)MOF A 801 (-3.4A)MOF A 801 (-2.9A)NoneMOF A 801 (-3.7A)MOF A 801 (-4.2A)MOF A 801 (-4.4A)MOF A 801 (-3.7A)MOF A 801 (-3.9A) | 0.43A | 3gn8A-4p6wA:38.8 | 3gn8A-4p6wA:76.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3GN8_A_DEXA247_1 (GLUCOCORTICOIDRECEPTOR 2) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | TRP A 600MET A 601GLN A 642MET A 646CYH A 736 | NoneMOF A 801 (-3.7A)NoneMOF A 801 (-4.4A)MOF A 801 (-3.7A) | 1.04A | 3gn8A-4p6wA:38.8 | 3gn8A-4p6wA:76.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3GN8_B_DEXB247_1 (GLUCOCORTICOIDRECEPTOR 2) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 7 / 12 | ASN A 564GLY A 568GLN A 570TRP A 600MET A 601CYH A 736PHE A 749 | MOF A 801 (-3.0A)NoneMOF A 801 (-2.9A)NoneMOF A 801 (-3.7A)MOF A 801 (-3.7A)MOF A 801 (-4.4A) | 1.08A | 3gn8B-4p6wA:39.0 | 3gn8B-4p6wA:76.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3GN8_B_DEXB247_1 (GLUCOCORTICOIDRECEPTOR 2) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 11 / 12 | LEU A 563ASN A 564GLY A 567GLN A 570TRP A 600MET A 601ARG A 611MET A 646CYH A 736THR A 739PHE A 749 | MOF A 801 (-3.9A)MOF A 801 (-3.0A)MOF A 801 (-3.4A)MOF A 801 (-2.9A)NoneMOF A 801 (-3.7A)MOF A 801 (-4.2A)MOF A 801 (-4.4A)MOF A 801 (-3.7A)MOF A 801 (-3.9A)MOF A 801 (-4.4A) | 0.45A | 3gn8B-4p6wA:39.0 | 3gn8B-4p6wA:76.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H52_A_486A3_1 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 9 / 12 | LEU A 563ASN A 564GLY A 567GLN A 570VAL A 571MET A 601ARG A 611MET A 646LEU A 732 | MOF A 801 (-3.9A)MOF A 801 (-3.0A)MOF A 801 (-3.4A)MOF A 801 (-2.9A)NoneMOF A 801 (-3.7A)MOF A 801 (-4.2A)MOF A 801 (-4.4A)MOF A 801 ( 4.2A) | 0.61A | 3h52A-4p6wA:27.4 | 3h52A-4p6wA:94.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H52_A_486A3_1 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 7 / 12 | MET A 560ASN A 564VAL A 571MET A 601ARG A 611MET A 646LEU A 732 | MOF A 801 (-3.9A)MOF A 801 (-3.0A)NoneMOF A 801 (-3.7A)MOF A 801 (-4.2A)MOF A 801 (-4.4A)MOF A 801 ( 4.2A) | 0.87A | 3h52A-4p6wA:27.4 | 3h52A-4p6wA:94.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H52_B_486B1_1 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 5 / 10 | LEU A 563TRP A 600MET A 601LEU A 732TYR A 735 | MOF A 801 (-3.9A)NoneMOF A 801 (-3.7A)MOF A 801 ( 4.2A)MOF A 801 (-4.8A) | 0.66A | 3h52B-4p6wA:29.3 | 3h52B-4p6wA:94.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H52_B_486B1_1 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 5 / 10 | LEU A 563TRP A 600MET A 601MET A 604LEU A 732 | MOF A 801 (-3.9A)NoneMOF A 801 (-3.7A)NoneMOF A 801 ( 4.2A) | 0.76A | 3h52B-4p6wA:29.3 | 3h52B-4p6wA:94.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H52_B_486B1_1 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 5 / 10 | TRP A 600MET A 601GLN A 642LEU A 732TYR A 735 | NoneMOF A 801 (-3.7A)NoneMOF A 801 ( 4.2A)MOF A 801 (-4.8A) | 1.23A | 3h52B-4p6wA:29.3 | 3h52B-4p6wA:94.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H52_B_486B1_2 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 9 / 12 | GLY A 567GLY A 568GLN A 570VAL A 571LEU A 608ARG A 611MET A 639CYH A 643MET A 646 | MOF A 801 (-3.4A)NoneMOF A 801 (-2.9A)NoneMOF A 801 ( 4.6A)MOF A 801 (-4.2A)MOF A 801 (-3.7A)MOF A 801 ( 3.7A)MOF A 801 (-4.4A) | 0.68A | 3h52B-4p6wA:29.3 | 3h52B-4p6wA:94.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H52_B_486B1_2 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 10 / 12 | GLY A 567GLY A 568GLN A 570VAL A 571LEU A 608ARG A 611MET A 639MET A 646CYH A 736ILE A 756 | MOF A 801 (-3.4A)NoneMOF A 801 (-2.9A)NoneMOF A 801 ( 4.6A)MOF A 801 (-4.2A)MOF A 801 (-3.7A)MOF A 801 (-4.4A)MOF A 801 (-3.7A)None | 0.72A | 3h52B-4p6wA:29.3 | 3h52B-4p6wA:94.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H52_B_486B1_2 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 6 / 12 | GLY A 567LEU A 608ARG A 611CYH A 643MET A 646ILE A 757 | MOF A 801 (-3.4A)MOF A 801 ( 4.6A)MOF A 801 (-4.2A)MOF A 801 ( 3.7A)MOF A 801 (-4.4A)None | 1.32A | 3h52B-4p6wA:29.3 | 3h52B-4p6wA:94.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H52_B_486B1_2 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | GLY A 568GLN A 570VAL A 571CYH A 736ILE A 756 | NoneMOF A 801 (-2.9A)NoneMOF A 801 (-3.7A)None | 1.09A | 3h52B-4p6wA:29.3 | 3h52B-4p6wA:94.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H52_B_486B1_2 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 8 / 12 | MET A 560GLY A 568VAL A 571LEU A 608ARG A 611MET A 639CYH A 643MET A 646 | MOF A 801 (-3.9A)NoneNoneMOF A 801 ( 4.6A)MOF A 801 (-4.2A)MOF A 801 (-3.7A)MOF A 801 ( 3.7A)MOF A 801 (-4.4A) | 0.87A | 3h52B-4p6wA:29.3 | 3h52B-4p6wA:94.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H52_B_486B1_2 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 9 / 12 | MET A 560GLY A 568VAL A 571LEU A 608ARG A 611MET A 639MET A 646CYH A 736ILE A 756 | MOF A 801 (-3.9A)NoneNoneMOF A 801 ( 4.6A)MOF A 801 (-4.2A)MOF A 801 (-3.7A)MOF A 801 (-4.4A)MOF A 801 (-3.7A)None | 0.93A | 3h52B-4p6wA:29.3 | 3h52B-4p6wA:94.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H52_C_486C4_1 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 9 / 12 | GLY A 567GLN A 570VAL A 571TRP A 600MET A 601LEU A 608ARG A 611PHE A 623MET A 646 | MOF A 801 (-3.4A)MOF A 801 (-2.9A)NoneNoneMOF A 801 (-3.7A)MOF A 801 ( 4.6A)MOF A 801 (-4.2A)MOF A 801 (-4.7A)MOF A 801 (-4.4A) | 0.66A | 3h52C-4p6wA:26.8 | 3h52C-4p6wA:94.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H52_C_486C4_1 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | GLY A 568GLN A 570VAL A 571TRP A 600MET A 601 | NoneMOF A 801 (-2.9A)NoneNoneMOF A 801 (-3.7A) | 1.02A | 3h52C-4p6wA:26.8 | 3h52C-4p6wA:94.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H52_C_486C4_1 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 7 / 12 | LEU A 563GLY A 567GLN A 570VAL A 571TRP A 600MET A 601PHE A 623 | MOF A 801 (-3.9A)MOF A 801 (-3.4A)MOF A 801 (-2.9A)NoneNoneMOF A 801 (-3.7A)MOF A 801 (-4.7A) | 0.99A | 3h52C-4p6wA:26.8 | 3h52C-4p6wA:94.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H52_C_486C4_1 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | LEU A 627GLN A 570LEU A 608PHE A 623MET A 646 | NoneMOF A 801 (-2.9A)MOF A 801 ( 4.6A)MOF A 801 (-4.7A)MOF A 801 (-4.4A) | 1.33A | 3h52C-4p6wA:26.8 | 3h52C-4p6wA:94.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H52_D_486D2_1 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 9 / 12 | GLY A 567GLN A 570VAL A 571MET A 601LEU A 608ARG A 611MET A 639MET A 646LEU A 732 | MOF A 801 (-3.4A)MOF A 801 (-2.9A)NoneMOF A 801 (-3.7A)MOF A 801 ( 4.6A)MOF A 801 (-4.2A)MOF A 801 (-3.7A)MOF A 801 (-4.4A)MOF A 801 ( 4.2A) | 0.63A | 3h52D-4p6wA:28.2 | 3h52D-4p6wA:94.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H52_D_486D2_1 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 9 / 12 | GLY A 567GLN A 570VAL A 571MET A 601LEU A 608ARG A 611MET A 646LEU A 732CYH A 736 | MOF A 801 (-3.4A)MOF A 801 (-2.9A)NoneMOF A 801 (-3.7A)MOF A 801 ( 4.6A)MOF A 801 (-4.2A)MOF A 801 (-4.4A)MOF A 801 ( 4.2A)MOF A 801 (-3.7A) | 0.67A | 3h52D-4p6wA:28.2 | 3h52D-4p6wA:94.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H52_D_486D2_1 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | GLY A 568GLN A 570VAL A 571MET A 601CYH A 736 | NoneMOF A 801 (-2.9A)NoneMOF A 801 (-3.7A)MOF A 801 (-3.7A) | 1.27A | 3h52D-4p6wA:28.2 | 3h52D-4p6wA:94.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H52_D_486D2_1 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 8 / 12 | MET A 560VAL A 571MET A 601LEU A 608ARG A 611MET A 639MET A 646LEU A 732 | MOF A 801 (-3.9A)NoneMOF A 801 (-3.7A)MOF A 801 ( 4.6A)MOF A 801 (-4.2A)MOF A 801 (-3.7A)MOF A 801 (-4.4A)MOF A 801 ( 4.2A) | 0.86A | 3h52D-4p6wA:28.2 | 3h52D-4p6wA:94.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3MNE_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 12 / 12 | MET A 560ASN A 564GLY A 567GLN A 570TRP A 600MET A 601ARG A 611MET A 646LEU A 732THR A 739ILE A 747PHE A 749 | MOF A 801 (-3.9A)MOF A 801 (-3.0A)MOF A 801 (-3.4A)MOF A 801 (-2.9A)NoneMOF A 801 (-3.7A)MOF A 801 (-4.2A)MOF A 801 (-4.4A)MOF A 801 ( 4.2A)MOF A 801 (-3.9A)MOF A 801 ( 4.4A)MOF A 801 (-4.4A) | 0.49A | 3mneA-4p6wA:37.7 | 3mneA-4p6wA:92.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3MNE_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 9 / 12 | MET A 560ASN A 564GLY A 568GLN A 570TRP A 600MET A 601THR A 739ILE A 747PHE A 749 | MOF A 801 (-3.9A)MOF A 801 (-3.0A)NoneMOF A 801 (-2.9A)NoneMOF A 801 (-3.7A)MOF A 801 (-3.9A)MOF A 801 ( 4.4A)MOF A 801 (-4.4A) | 1.05A | 3mneA-4p6wA:37.7 | 3mneA-4p6wA:92.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 11 / 12 | ASN A 564GLY A 567GLN A 570MET A 601ARG A 611MET A 646LEU A 732CYH A 736THR A 739ILE A 747PHE A 749 | MOF A 801 (-3.0A)MOF A 801 (-3.4A)MOF A 801 (-2.9A)MOF A 801 (-3.7A)MOF A 801 (-4.2A)MOF A 801 (-4.4A)MOF A 801 ( 4.2A)MOF A 801 (-3.7A)MOF A 801 (-3.9A)MOF A 801 ( 4.4A)MOF A 801 (-4.4A) | 0.59A | 3mnoA-4p6wA:36.9 | 3mnoA-4p6wA:92.46 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 7 / 12 | ASN A 564GLY A 568MET A 601CYH A 736THR A 739ILE A 747PHE A 749 | MOF A 801 (-3.0A)NoneMOF A 801 (-3.7A)MOF A 801 (-3.7A)MOF A 801 (-3.9A)MOF A 801 ( 4.4A)MOF A 801 (-4.4A) | 0.90A | 3mnoA-4p6wA:36.9 | 3mnoA-4p6wA:92.46 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3MNO_A_DEXA784_2 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 4 / 6 | LEU A 563TRP A 600MET A 604TYR A 735 | MOF A 801 (-3.9A)NoneNoneMOF A 801 (-4.8A) | 0.76A | 3mnoA-4p6wA:36.9 | 3mnoA-4p6wA:92.46 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3MNO_A_DEXA784_2 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 4 / 6 | MET A 560LEU A 563TRP A 600MET A 604 | MOF A 801 (-3.9A)MOF A 801 (-3.9A)NoneNone | 0.22A | 3mnoA-4p6wA:36.9 | 3mnoA-4p6wA:92.46 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 11 / 12 | ASN A 564GLY A 567GLN A 570MET A 601ARG A 611MET A 646LEU A 732CYH A 736THR A 739ILE A 747PHE A 749 | MOF A 801 (-3.0A)MOF A 801 (-3.4A)MOF A 801 (-2.9A)MOF A 801 (-3.7A)MOF A 801 (-4.2A)MOF A 801 (-4.4A)MOF A 801 ( 4.2A)MOF A 801 (-3.7A)MOF A 801 (-3.9A)MOF A 801 ( 4.4A)MOF A 801 (-4.4A) | 0.63A | 3mnpA-4p6wA:37.7 | 3mnpA-4p6wA:91.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 7 / 12 | ASN A 564GLY A 568MET A 601CYH A 736THR A 739ILE A 747PHE A 749 | MOF A 801 (-3.0A)NoneMOF A 801 (-3.7A)MOF A 801 (-3.7A)MOF A 801 (-3.9A)MOF A 801 ( 4.4A)MOF A 801 (-4.4A) | 0.91A | 3mnpA-4p6wA:37.7 | 3mnpA-4p6wA:91.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3MNP_A_DEXA784_2 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 4 / 6 | LEU A 563TRP A 600MET A 604TYR A 735 | MOF A 801 (-3.9A)NoneNoneMOF A 801 (-4.8A) | 0.74A | 3mnpA-4p6wA:37.7 | 3mnpA-4p6wA:91.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3MNP_A_DEXA784_2 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 4 / 6 | MET A 560LEU A 563TRP A 600MET A 604 | MOF A 801 (-3.9A)MOF A 801 (-3.9A)NoneNone | 0.21A | 3mnpA-4p6wA:37.7 | 3mnpA-4p6wA:91.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3OLL_A_ESTA600_1 (ESTROGEN RECEPTORBETA) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 5 / 10 | LEU A 563LEU A 566MET A 601LEU A 608ARG A 611 | MOF A 801 (-3.9A)MOF A 801 ( 4.6A)MOF A 801 (-3.7A)MOF A 801 ( 4.6A)MOF A 801 (-4.2A) | 0.69A | 3ollA-4p6wA:27.2 | 3ollA-4p6wA:29.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3OLL_A_ESTA600_1 (ESTROGEN RECEPTORBETA) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 5 / 10 | MET A 560LEU A 566MET A 601LEU A 608ARG A 611 | MOF A 801 (-3.9A)MOF A 801 ( 4.6A)MOF A 801 (-3.7A)MOF A 801 ( 4.6A)MOF A 801 (-4.2A) | 0.81A | 3ollA-4p6wA:27.2 | 3ollA-4p6wA:29.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3OLS_A_ESTA600_1 (ESTROGEN RECEPTORBETA) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | LEU A 563LEU A 566MET A 601LEU A 608ARG A 611 | MOF A 801 (-3.9A)MOF A 801 ( 4.6A)MOF A 801 (-3.7A)MOF A 801 ( 4.6A)MOF A 801 (-4.2A) | 0.68A | 3olsA-4p6wA:28.3 | 3olsA-4p6wA:29.89 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3VHU_A_SNLA1001_1 (MINERALOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 9 / 12 | ASN A 564GLN A 570MET A 601LEU A 608ARG A 611LEU A 732CYH A 736THR A 739PHE A 749 | MOF A 801 (-3.0A)MOF A 801 (-2.9A)MOF A 801 (-3.7A)MOF A 801 ( 4.6A)MOF A 801 (-4.2A)MOF A 801 ( 4.2A)MOF A 801 (-3.7A)MOF A 801 (-3.9A)MOF A 801 (-4.4A) | 0.38A | 3vhuA-4p6wA:35.0 | 3vhuA-4p6wA:56.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3VHU_A_SNLA1001_1 (MINERALOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | ASN A 564LEU A 621CYH A 736THR A 739PHE A 749 | MOF A 801 (-3.0A)NoneMOF A 801 (-3.7A)MOF A 801 (-3.9A)MOF A 801 (-4.4A) | 1.14A | 3vhuA-4p6wA:35.0 | 3vhuA-4p6wA:56.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ZQT_A_TESA1000_1 (ANDROGEN RECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 6 / 12 | LEU A 563ASN A 564LEU A 566MET A 601MET A 604ARG A 611 | MOF A 801 (-3.9A)MOF A 801 (-3.0A)MOF A 801 ( 4.6A)MOF A 801 (-3.7A)NoneMOF A 801 (-4.2A) | 0.91A | 3zqtA-4p6wA:33.4 | 3zqtA-4p6wA:49.61 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ZQT_A_TESA1000_1 (ANDROGEN RECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | LEU A 566GLN A 570MET A 601MET A 604ARG A 611 | MOF A 801 ( 4.6A)MOF A 801 (-2.9A)MOF A 801 (-3.7A)NoneMOF A 801 (-4.2A) | 1.01A | 3zqtA-4p6wA:33.4 | 3zqtA-4p6wA:49.61 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FN9_A_STRA301_1 (STEROID RECEPTOR 2) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 9 / 12 | LEU A 563ASN A 564LEU A 566GLN A 570MET A 601ALA A 605ARG A 611CYH A 736THR A 739 | MOF A 801 (-3.9A)MOF A 801 (-3.0A)MOF A 801 ( 4.6A)MOF A 801 (-2.9A)MOF A 801 (-3.7A)MOF A 801 ( 4.8A)MOF A 801 (-4.2A)MOF A 801 (-3.7A)MOF A 801 (-3.9A) | 0.64A | 4fn9A-4p6wA:35.7 | 4fn9A-4p6wA:62.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FN9_B_STRB301_1 (STEROID RECEPTOR 2) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 8 / 12 | LEU A 563ASN A 564LEU A 566GLN A 570TRP A 600MET A 601ARG A 611THR A 739 | MOF A 801 (-3.9A)MOF A 801 (-3.0A)MOF A 801 ( 4.6A)MOF A 801 (-2.9A)NoneMOF A 801 (-3.7A)MOF A 801 (-4.2A)MOF A 801 (-3.9A) | 0.58A | 4fn9B-4p6wA:36.1 | 4fn9B-4p6wA:62.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4HLW_A_TESA1001_1 (ANDROGEN RECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 6 / 12 | ASN A 564GLY A 568GLN A 570TRP A 600MET A 601MET A 604 | MOF A 801 (-3.0A)NoneMOF A 801 (-2.9A)NoneMOF A 801 (-3.7A)None | 1.37A | 4hlwA-4p6wA:33.3 | 4hlwA-4p6wA:49.61 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4HLW_A_TESA1001_1 (ANDROGEN RECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 8 / 12 | LEU A 563ASN A 564GLY A 567GLN A 570TRP A 600MET A 601MET A 604ARG A 611 | MOF A 801 (-3.9A)MOF A 801 (-3.0A)MOF A 801 (-3.4A)MOF A 801 (-2.9A)NoneMOF A 801 (-3.7A)NoneMOF A 801 (-4.2A) | 0.87A | 4hlwA-4p6wA:33.3 | 4hlwA-4p6wA:49.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4J24_A_ESTA600_1 (ESTROGEN RECEPTORBETA) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | LEU A 563LEU A 566MET A 601LEU A 608ARG A 611 | MOF A 801 (-3.9A)MOF A 801 ( 4.6A)MOF A 801 (-3.7A)MOF A 801 ( 4.6A)MOF A 801 (-4.2A) | 0.72A | 4j24A-4p6wA:28.2 | 4j24A-4p6wA:29.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4J24_A_ESTA600_1 (ESTROGEN RECEPTORBETA) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | MET A 560LEU A 566MET A 601LEU A 608ARG A 611 | MOF A 801 (-3.9A)MOF A 801 ( 4.6A)MOF A 801 (-3.7A)MOF A 801 ( 4.6A)MOF A 801 (-4.2A) | 0.87A | 4j24A-4p6wA:28.2 | 4j24A-4p6wA:29.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4J24_D_ESTD600_1 (ESTROGEN RECEPTORBETA) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | MET A 560LEU A 566MET A 601LEU A 608ARG A 611 | MOF A 801 (-3.9A)MOF A 801 ( 4.6A)MOF A 801 (-3.7A)MOF A 801 ( 4.6A)MOF A 801 (-4.2A) | 0.81A | 4j24D-4p6wA:27.9 | 4j24D-4p6wA:29.89 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4LTW_A_STRA301_1 (ANCESTRAL STEROIDRECEPTOR 2) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 8 / 12 | LEU A 563ASN A 564LEU A 566GLN A 570MET A 601ARG A 611LEU A 732CYH A 736 | MOF A 801 (-3.9A)MOF A 801 (-3.0A)MOF A 801 ( 4.6A)MOF A 801 (-2.9A)MOF A 801 (-3.7A)MOF A 801 (-4.2A)MOF A 801 ( 4.2A)MOF A 801 (-3.7A) | 0.55A | 4ltwA-4p6wA:36.6 | 4ltwA-4p6wA:62.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4LTW_A_STRA301_2 (ANCESTRAL STEROIDRECEPTOR 2) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 5 / 8 | TRP A 600ALA A 605MET A 646THR A 739PHE A 749 | NoneMOF A 801 ( 4.8A)MOF A 801 (-4.4A)MOF A 801 (-3.9A)MOF A 801 (-4.4A) | 0.75A | 4ltwA-4p6wA:36.6 | 4ltwA-4p6wA:62.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4LTW_A_STRA301_2 (ANCESTRAL STEROIDRECEPTOR 2) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 5 / 8 | TRP A 600MET A 604ALA A 605MET A 646PHE A 749 | NoneNoneMOF A 801 ( 4.8A)MOF A 801 (-4.4A)MOF A 801 (-4.4A) | 0.87A | 4ltwA-4p6wA:36.6 | 4ltwA-4p6wA:62.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OJB_A_198A1001_1 (ANDROGEN RECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 6 / 12 | LEU A 566GLY A 567GLN A 570MET A 601MET A 604ARG A 611 | MOF A 801 ( 4.6A)MOF A 801 (-3.4A)MOF A 801 (-2.9A)MOF A 801 (-3.7A)NoneMOF A 801 (-4.2A) | 0.87A | 4ojbA-4p6wA:32.5 | 4ojbA-4p6wA:50.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OJB_A_198A1001_2 (ANDROGEN RECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 4 / 7 | ASN A 564LEU A 732ILE A 756ILE A 757 | MOF A 801 (-3.0A)MOF A 801 ( 4.2A)NoneNone | 0.41A | 4ojbA-4p6wA:32.5 | 4ojbA-4p6wA:50.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OK1_A_198A1001_1 (ANDROGEN RECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | LEU A 563LEU A 566GLY A 567GLN A 570ARG A 611 | MOF A 801 (-3.9A)MOF A 801 ( 4.6A)MOF A 801 (-3.4A)MOF A 801 (-2.9A)MOF A 801 (-4.2A) | 0.68A | 4ok1A-4p6wA:32.9 | 4ok1A-4p6wA:50.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OK1_A_198A1001_1 (ANDROGEN RECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 6 / 12 | LEU A 566GLY A 567GLN A 570MET A 601ARG A 611ILE A 757 | MOF A 801 ( 4.6A)MOF A 801 (-3.4A)MOF A 801 (-2.9A)MOF A 801 (-3.7A)MOF A 801 (-4.2A)None | 0.66A | 4ok1A-4p6wA:32.9 | 4ok1A-4p6wA:50.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OKB_A_198A1002_1 (ANDROGEN RECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 6 / 12 | LEU A 566GLY A 567GLN A 570MET A 601ARG A 611ILE A 757 | MOF A 801 ( 4.6A)MOF A 801 (-3.4A)MOF A 801 (-2.9A)MOF A 801 (-3.7A)MOF A 801 (-4.2A)None | 0.82A | 4okbA-4p6wA:32.4 | 4okbA-4p6wA:50.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OKB_A_198A1002_1 (ANDROGEN RECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 6 / 12 | LEU A 566GLY A 567GLN A 570MET A 604ARG A 611ILE A 757 | MOF A 801 ( 4.6A)MOF A 801 (-3.4A)MOF A 801 (-2.9A)NoneMOF A 801 (-4.2A)None | 0.97A | 4okbA-4p6wA:32.4 | 4okbA-4p6wA:50.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OKT_A_198A1001_1 (ANDROGEN RECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 7 / 12 | LEU A 563LEU A 566GLY A 567GLN A 570MET A 601ARG A 611ILE A 757 | MOF A 801 (-3.9A)MOF A 801 ( 4.6A)MOF A 801 (-3.4A)MOF A 801 (-2.9A)MOF A 801 (-3.7A)MOF A 801 (-4.2A)None | 0.89A | 4oktA-4p6wA:32.4 | 4oktA-4p6wA:50.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OKT_A_198A1001_1 (ANDROGEN RECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 7 / 12 | LEU A 563LEU A 566GLY A 567GLN A 570MET A 601ARG A 611MET A 646 | MOF A 801 (-3.9A)MOF A 801 ( 4.6A)MOF A 801 (-3.4A)MOF A 801 (-2.9A)MOF A 801 (-3.7A)MOF A 801 (-4.2A)MOF A 801 (-4.4A) | 1.01A | 4oktA-4p6wA:32.4 | 4oktA-4p6wA:50.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OKW_A_198A1001_1 (ANDROGEN RECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 7 / 12 | LEU A 566GLY A 567GLN A 570MET A 601MET A 604ARG A 611ILE A 757 | MOF A 801 ( 4.6A)MOF A 801 (-3.4A)MOF A 801 (-2.9A)MOF A 801 (-3.7A)NoneMOF A 801 (-4.2A)None | 0.86A | 4okwA-4p6wA:32.4 | 4okwA-4p6wA:50.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OKX_A_198A1002_1 (ANDROGEN RECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 6 / 12 | LEU A 566GLY A 567GLN A 570MET A 601MET A 604ARG A 611 | MOF A 801 ( 4.6A)MOF A 801 (-3.4A)MOF A 801 (-2.9A)MOF A 801 (-3.7A)NoneMOF A 801 (-4.2A) | 0.86A | 4okxA-4p6wA:32.5 | 4okxA-4p6wA:50.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OLM_A_198A1001_1 (ANDROGEN RECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 6 / 12 | LEU A 563LEU A 566GLY A 567GLN A 570MET A 604ARG A 611 | MOF A 801 (-3.9A)MOF A 801 ( 4.6A)MOF A 801 (-3.4A)MOF A 801 (-2.9A)NoneMOF A 801 (-4.2A) | 0.86A | 4olmA-4p6wA:32.1 | 4olmA-4p6wA:50.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OLM_A_198A1001_1 (ANDROGEN RECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 6 / 12 | LEU A 566GLY A 567GLN A 570MET A 601MET A 604ARG A 611 | MOF A 801 ( 4.6A)MOF A 801 (-3.4A)MOF A 801 (-2.9A)MOF A 801 (-3.7A)NoneMOF A 801 (-4.2A) | 0.94A | 4olmA-4p6wA:32.1 | 4olmA-4p6wA:50.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_A_HCYA900_1 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | ASN A 564GLY A 567LEU A 627THR A 739PHE A 749 | MOF A 801 (-3.0A)MOF A 801 (-3.4A)NoneMOF A 801 (-3.9A)MOF A 801 (-4.4A) | 1.44A | 4p6xA-4p6wA:39.3 | 4p6xA-4p6wA:98.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_A_HCYA900_1 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | ASN A 564GLY A 568MET A 601ILE A 747PHE A 749 | MOF A 801 (-3.0A)NoneMOF A 801 (-3.7A)MOF A 801 ( 4.4A)MOF A 801 (-4.4A) | 0.90A | 4p6xA-4p6wA:39.3 | 4p6xA-4p6wA:98.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_A_HCYA900_1 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 11 / 12 | MET A 560LEU A 563ASN A 564GLY A 567GLN A 570MET A 601LEU A 608ARG A 611THR A 739ILE A 747PHE A 749 | MOF A 801 (-3.9A)MOF A 801 (-3.9A)MOF A 801 (-3.0A)MOF A 801 (-3.4A)MOF A 801 (-2.9A)MOF A 801 (-3.7A)MOF A 801 ( 4.6A)MOF A 801 (-4.2A)MOF A 801 (-3.9A)MOF A 801 ( 4.4A)MOF A 801 (-4.4A) | 0.52A | 4p6xA-4p6wA:39.3 | 4p6xA-4p6wA:98.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_A_HCYA900_1 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | MET A 560LEU A 563LEU A 621THR A 739ILE A 747 | MOF A 801 (-3.9A)MOF A 801 (-3.9A)NoneMOF A 801 (-3.9A)MOF A 801 ( 4.4A) | 1.25A | 4p6xA-4p6wA:39.3 | 4p6xA-4p6wA:98.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_C_HCYC900_1 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 10 / 11 | MET A 560ASN A 564LEU A 566GLN A 570TRP A 600MET A 601MET A 604ARG A 611THR A 739ILE A 747 | MOF A 801 (-3.9A)MOF A 801 (-3.0A)MOF A 801 ( 4.6A)MOF A 801 (-2.9A)NoneMOF A 801 (-3.7A)NoneMOF A 801 (-4.2A)MOF A 801 (-3.9A)MOF A 801 ( 4.4A) | 0.41A | 4p6xC-4p6wA:40.4 | 4p6xC-4p6wA:98.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_E_HCYE900_1 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | ASN A 564GLY A 567LEU A 627THR A 739PHE A 749 | MOF A 801 (-3.0A)MOF A 801 (-3.4A)NoneMOF A 801 (-3.9A)MOF A 801 (-4.4A) | 1.44A | 4p6xE-4p6wA:39.5 | 4p6xE-4p6wA:98.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_E_HCYE900_1 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 6 / 12 | ASN A 564GLY A 568MET A 601THR A 739ILE A 747PHE A 749 | MOF A 801 (-3.0A)NoneMOF A 801 (-3.7A)MOF A 801 (-3.9A)MOF A 801 ( 4.4A)MOF A 801 (-4.4A) | 0.97A | 4p6xE-4p6wA:39.5 | 4p6xE-4p6wA:98.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_E_HCYE900_1 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 11 / 12 | LEU A 563ASN A 564GLY A 567GLN A 570MET A 601MET A 604LEU A 608ARG A 611THR A 739ILE A 747PHE A 749 | MOF A 801 (-3.9A)MOF A 801 (-3.0A)MOF A 801 (-3.4A)MOF A 801 (-2.9A)MOF A 801 (-3.7A)NoneMOF A 801 ( 4.6A)MOF A 801 (-4.2A)MOF A 801 (-3.9A)MOF A 801 ( 4.4A)MOF A 801 (-4.4A) | 0.39A | 4p6xE-4p6wA:39.5 | 4p6xE-4p6wA:98.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_E_HCYE900_1 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | LEU A 563LEU A 621THR A 739ILE A 747PHE A 749 | MOF A 801 (-3.9A)NoneMOF A 801 (-3.9A)MOF A 801 ( 4.4A)MOF A 801 (-4.4A) | 1.46A | 4p6xE-4p6wA:39.5 | 4p6xE-4p6wA:98.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_G_HCYG900_1 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 11 / 12 | ASN A 564GLY A 567GLN A 570TRP A 600MET A 601LEU A 608ARG A 611MET A 646THR A 739ILE A 747PHE A 749 | MOF A 801 (-3.0A)MOF A 801 (-3.4A)MOF A 801 (-2.9A)NoneMOF A 801 (-3.7A)MOF A 801 ( 4.6A)MOF A 801 (-4.2A)MOF A 801 (-4.4A)MOF A 801 (-3.9A)MOF A 801 ( 4.4A)MOF A 801 (-4.4A) | 0.42A | 4p6xG-4p6wA:40.5 | 4p6xG-4p6wA:98.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_G_HCYG900_1 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | ASN A 564GLY A 567LEU A 627THR A 739PHE A 749 | MOF A 801 (-3.0A)MOF A 801 (-3.4A)NoneMOF A 801 (-3.9A)MOF A 801 (-4.4A) | 1.42A | 4p6xG-4p6wA:40.5 | 4p6xG-4p6wA:98.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_G_HCYG900_1 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 7 / 12 | ASN A 564GLY A 568TRP A 600MET A 601THR A 739ILE A 747PHE A 749 | MOF A 801 (-3.0A)NoneNoneMOF A 801 (-3.7A)MOF A 801 (-3.9A)MOF A 801 ( 4.4A)MOF A 801 (-4.4A) | 0.94A | 4p6xG-4p6wA:40.5 | 4p6xG-4p6wA:98.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_G_HCYG900_1 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | MET A 601LEU A 608ARG A 611GLN A 642MET A 646 | MOF A 801 (-3.7A)MOF A 801 ( 4.6A)MOF A 801 (-4.2A)NoneMOF A 801 (-4.4A) | 0.92A | 4p6xG-4p6wA:40.5 | 4p6xG-4p6wA:98.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_I_HCYI900_1 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | ASN A 564GLY A 567LEU A 627THR A 739PHE A 749 | MOF A 801 (-3.0A)MOF A 801 (-3.4A)NoneMOF A 801 (-3.9A)MOF A 801 (-4.4A) | 1.44A | 4p6xI-4p6wA:40.4 | 4p6xI-4p6wA:98.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_I_HCYI900_1 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 7 / 12 | ASN A 564GLY A 568GLN A 570MET A 601THR A 739ILE A 747PHE A 749 | MOF A 801 (-3.0A)NoneMOF A 801 (-2.9A)MOF A 801 (-3.7A)MOF A 801 (-3.9A)MOF A 801 ( 4.4A)MOF A 801 (-4.4A) | 1.14A | 4p6xI-4p6wA:40.4 | 4p6xI-4p6wA:98.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_I_HCYI900_1 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 11 / 12 | LEU A 563ASN A 564GLY A 567GLN A 570MET A 601LEU A 608ARG A 611MET A 646THR A 739ILE A 747PHE A 749 | MOF A 801 (-3.9A)MOF A 801 (-3.0A)MOF A 801 (-3.4A)MOF A 801 (-2.9A)MOF A 801 (-3.7A)MOF A 801 ( 4.6A)MOF A 801 (-4.2A)MOF A 801 (-4.4A)MOF A 801 (-3.9A)MOF A 801 ( 4.4A)MOF A 801 (-4.4A) | 0.43A | 4p6xI-4p6wA:40.4 | 4p6xI-4p6wA:98.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_K_HCYK900_1 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 7 / 12 | ASN A 564GLY A 568TRP A 600MET A 601THR A 739ILE A 747PHE A 749 | MOF A 801 (-3.0A)NoneNoneMOF A 801 (-3.7A)MOF A 801 (-3.9A)MOF A 801 ( 4.4A)MOF A 801 (-4.4A) | 0.95A | 4p6xK-4p6wA:40.6 | 4p6xK-4p6wA:98.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_K_HCYK900_1 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 11 / 12 | MET A 560ASN A 564GLY A 567GLN A 570TRP A 600MET A 601ARG A 611MET A 646THR A 739ILE A 747PHE A 749 | MOF A 801 (-3.9A)MOF A 801 (-3.0A)MOF A 801 (-3.4A)MOF A 801 (-2.9A)NoneMOF A 801 (-3.7A)MOF A 801 (-4.2A)MOF A 801 (-4.4A)MOF A 801 (-3.9A)MOF A 801 ( 4.4A)MOF A 801 (-4.4A) | 0.41A | 4p6xK-4p6wA:40.6 | 4p6xK-4p6wA:98.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4UDA_A_DEXA1985_1 (MINERALOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 8 / 12 | ASN A 564GLN A 570MET A 601ARG A 611MET A 646LEU A 732CYH A 736PHE A 749 | MOF A 801 (-3.0A)MOF A 801 (-2.9A)MOF A 801 (-3.7A)MOF A 801 (-4.2A)MOF A 801 (-4.4A)MOF A 801 ( 4.2A)MOF A 801 (-3.7A)MOF A 801 (-4.4A) | 0.62A | 4udaA-4p6wA:35.5 | 4udaA-4p6wA:56.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4UDC_A_DEXA1778_1 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 7 / 12 | ASN A 564GLY A 568GLN A 570TRP A 600MET A 601ILE A 747PHE A 749 | MOF A 801 (-3.0A)NoneMOF A 801 (-2.9A)NoneMOF A 801 (-3.7A)MOF A 801 ( 4.4A)MOF A 801 (-4.4A) | 1.13A | 4udcA-4p6wA:39.7 | 4udcA-4p6wA:96.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4UDC_A_DEXA1778_1 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 12 / 12 | MET A 560LEU A 563ASN A 564GLY A 567GLN A 570TRP A 600MET A 601ARG A 611MET A 646THR A 739ILE A 747PHE A 749 | MOF A 801 (-3.9A)MOF A 801 (-3.9A)MOF A 801 (-3.0A)MOF A 801 (-3.4A)MOF A 801 (-2.9A)NoneMOF A 801 (-3.7A)MOF A 801 (-4.2A)MOF A 801 (-4.4A)MOF A 801 (-3.9A)MOF A 801 ( 4.4A)MOF A 801 (-4.4A) | 0.52A | 4udcA-4p6wA:39.7 | 4udcA-4p6wA:96.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5GS4_A_ESTA603_1 (ESTROGEN RECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | MET A 560LEU A 566LEU A 608ARG A 611MET A 639 | MOF A 801 (-3.9A)MOF A 801 ( 4.6A)MOF A 801 ( 4.6A)MOF A 801 (-4.2A)MOF A 801 (-3.7A) | 1.14A | 5gs4A-4p6wA:26.2 | 5gs4A-4p6wA:30.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5KT8_B_NIZB809_1 (CATALASE-PEROXIDASE) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 5 / 9 | ARG A 611VAL A 543GLY A 609SER A 612LEU A 608 | MOF A 801 (-4.2A)NoneNoneNoneMOF A 801 ( 4.6A) | 1.34A | 5kt8B-4p6wA:0.8 | 5kt8B-4p6wA:15.19 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5MWY_A_YNUA1101_0 (MINERALOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 6 / 12 | LEU A 563ASN A 564TRP A 600MET A 601LEU A 608LEU A 732 | MOF A 801 (-3.9A)MOF A 801 (-3.0A)NoneMOF A 801 (-3.7A)MOF A 801 ( 4.6A)MOF A 801 ( 4.2A) | 0.53A | 5mwyA-4p6wA:35.3 | 5mwyA-4p6wA:52.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5MWY_A_YNUA1101_1 (MINERALOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 6 / 6 | GLN A 570ARG A 611PHE A 623CYH A 736THR A 739PHE A 749 | MOF A 801 (-2.9A)MOF A 801 (-4.2A)MOF A 801 (-4.7A)MOF A 801 (-3.7A)MOF A 801 (-3.9A)MOF A 801 (-4.4A) | 0.36A | 5mwyA-4p6wA:35.3 | 5mwyA-4p6wA:52.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5NFP_A_8W5A804_1 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 6 / 12 | ASN A 564GLY A 568GLN A 570MET A 601THR A 739PHE A 749 | MOF A 801 (-3.0A)NoneMOF A 801 (-2.9A)MOF A 801 (-3.7A)MOF A 801 (-3.9A)MOF A 801 (-4.4A) | 1.20A | 5nfpA-4p6wA:39.5 | 5nfpA-4p6wA:96.43 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5NFP_A_8W5A804_1 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 7 / 12 | GLN A 570MET A 601ARG A 611GLN A 642CYH A 643MET A 646THR A 739 | MOF A 801 (-2.9A)MOF A 801 (-3.7A)MOF A 801 (-4.2A)NoneMOF A 801 ( 3.7A)MOF A 801 (-4.4A)MOF A 801 (-3.9A) | 1.11A | 5nfpA-4p6wA:39.5 | 5nfpA-4p6wA:96.43 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5NFP_A_8W5A804_1 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 11 / 12 | MET A 560ASN A 564GLY A 567GLN A 570MET A 601ARG A 611MET A 639CYH A 643MET A 646THR A 739PHE A 749 | MOF A 801 (-3.9A)MOF A 801 (-3.0A)MOF A 801 (-3.4A)MOF A 801 (-2.9A)MOF A 801 (-3.7A)MOF A 801 (-4.2A)MOF A 801 (-3.7A)MOF A 801 ( 3.7A)MOF A 801 (-4.4A)MOF A 801 (-3.9A)MOF A 801 (-4.4A) | 0.61A | 5nfpA-4p6wA:39.5 | 5nfpA-4p6wA:96.43 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5NFP_A_8W5A804_2 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 4 / 4 | LEU A 563MET A 604ILE A 747LEU A 753 | MOF A 801 (-3.9A)NoneMOF A 801 ( 4.4A)None | 0.38A | 5nfpA-4p6wA:39.5 | 5nfpA-4p6wA:96.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5SXS_B_NIZB806_1 (CATALASE-PEROXIDASE) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 5 / 9 | ARG A 611VAL A 543GLY A 609SER A 612LEU A 608 | MOF A 801 (-4.2A)NoneNoneNoneMOF A 801 ( 4.6A) | 1.33A | 5sxsB-4p6wA:1.2 | 5sxsB-4p6wA:15.19 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5TOA_A_ESTA601_1 (ESTROGEN RECEPTORBETA) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | LEU A 563LEU A 566MET A 601LEU A 608ARG A 611 | MOF A 801 (-3.9A)MOF A 801 ( 4.6A)MOF A 801 (-3.7A)MOF A 801 ( 4.6A)MOF A 801 (-4.2A) | 0.71A | 5toaA-4p6wA:25.6 | 5toaA-4p6wA:29.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5UC1_A_486A801_1 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 11 / 12 | LEU A 563LEU A 566GLY A 567GLY A 568GLN A 570VAL A 571MET A 604LEU A 608ARG A 611CYH A 643MET A 646 | MOF A 801 (-3.9A)MOF A 801 ( 4.6A)MOF A 801 (-3.4A)NoneMOF A 801 (-2.9A)NoneNoneMOF A 801 ( 4.6A)MOF A 801 (-4.2A)MOF A 801 ( 3.7A)MOF A 801 (-4.4A) | 0.83A | 5uc1A-4p6wA:26.2 | 5uc1A-4p6wA:96.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5UC1_A_486A801_1 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 11 / 12 | LEU A 566GLY A 567GLY A 568GLN A 570VAL A 571TRP A 600MET A 604LEU A 608ARG A 611CYH A 643MET A 646 | MOF A 801 ( 4.6A)MOF A 801 (-3.4A)NoneMOF A 801 (-2.9A)NoneNoneNoneMOF A 801 ( 4.6A)MOF A 801 (-4.2A)MOF A 801 ( 3.7A)MOF A 801 (-4.4A) | 0.93A | 5uc1A-4p6wA:26.2 | 5uc1A-4p6wA:96.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5UC1_B_486B801_2 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 12 / 12 | LEU A 563ASN A 564LEU A 566GLY A 567GLY A 568GLN A 570VAL A 571MET A 604LEU A 608ARG A 611CYH A 643MET A 646 | MOF A 801 (-3.9A)MOF A 801 (-3.0A)MOF A 801 ( 4.6A)MOF A 801 (-3.4A)NoneMOF A 801 (-2.9A)NoneNoneMOF A 801 ( 4.6A)MOF A 801 (-4.2A)MOF A 801 ( 3.7A)MOF A 801 (-4.4A) | 0.87A | 5uc1B-4p6wA:26.3 | 5uc1B-4p6wA:96.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5UC3_A_486A801_1 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 9 / 12 | ASN A 564GLY A 567GLN A 570MET A 604ARG A 611PHE A 623MET A 639MET A 646LEU A 732 | MOF A 801 (-3.0A)MOF A 801 (-3.4A)MOF A 801 (-2.9A)NoneMOF A 801 (-4.2A)MOF A 801 (-4.7A)MOF A 801 (-3.7A)MOF A 801 (-4.4A)MOF A 801 ( 4.2A) | 0.69A | 5uc3A-4p6wA:34.1 | 5uc3A-4p6wA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5UC3_A_486A801_1 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 10 / 12 | ASN A 564GLY A 567GLN A 570TRP A 600ARG A 611PHE A 623MET A 639MET A 646LEU A 732CYH A 736 | MOF A 801 (-3.0A)MOF A 801 (-3.4A)MOF A 801 (-2.9A)NoneMOF A 801 (-4.2A)MOF A 801 (-4.7A)MOF A 801 (-3.7A)MOF A 801 (-4.4A)MOF A 801 ( 4.2A)MOF A 801 (-3.7A) | 0.70A | 5uc3A-4p6wA:34.1 | 5uc3A-4p6wA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5UC3_A_486A801_1 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 6 / 12 | MET A 560ASN A 564TRP A 600MET A 646LEU A 732CYH A 736 | MOF A 801 (-3.9A)MOF A 801 (-3.0A)NoneMOF A 801 (-4.4A)MOF A 801 ( 4.2A)MOF A 801 (-3.7A) | 1.00A | 5uc3A-4p6wA:34.1 | 5uc3A-4p6wA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5UC3_A_486A801_2 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 4 / 5 | LEU A 563LEU A 566MET A 601TYR A 735 | MOF A 801 (-3.9A)MOF A 801 ( 4.6A)MOF A 801 (-3.7A)MOF A 801 (-4.8A) | 1.01A | 5uc3A-4p6wA:34.1 | 5uc3A-4p6wA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5UC3_B_486B801_1 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 10 / 12 | LEU A 563GLY A 567GLN A 570VAL A 571TRP A 600ARG A 611PHE A 623MET A 646LEU A 732CYH A 736 | MOF A 801 (-3.9A)MOF A 801 (-3.4A)MOF A 801 (-2.9A)NoneNoneMOF A 801 (-4.2A)MOF A 801 (-4.7A)MOF A 801 (-4.4A)MOF A 801 ( 4.2A)MOF A 801 (-3.7A) | 0.63A | 5uc3B-4p6wA:33.4 | 5uc3B-4p6wA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5UC3_B_486B801_1 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 6 / 12 | MET A 560VAL A 571TRP A 600MET A 646LEU A 732CYH A 736 | MOF A 801 (-3.9A)NoneNoneMOF A 801 (-4.4A)MOF A 801 ( 4.2A)MOF A 801 (-3.7A) | 0.92A | 5uc3B-4p6wA:33.4 | 5uc3B-4p6wA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5UC3_B_486B801_1 (GLUCOCORTICOIDRECEPTOR) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | TRP A 600GLN A 642MET A 646LEU A 732CYH A 736 | NoneNoneMOF A 801 (-4.4A)MOF A 801 ( 4.2A)MOF A 801 (-3.7A) | 0.99A | 5uc3B-4p6wA:33.4 | 5uc3B-4p6wA:100.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6CDQ_A_NIZA809_1 (CATALASE-PEROXIDASE) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 5 / 9 | ARG A 611VAL A 543GLY A 609SER A 612LEU A 608 | MOF A 801 (-4.2A)NoneNoneNoneMOF A 801 ( 4.6A) | 1.37A | 6cdqA-4p6wA:undetectable | 6cdqA-4p6wA:13.22 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6CDQ_B_NIZB808_1 (CATALASE-PEROXIDASE) |
4p6w | GLUCOCORTICOIDRECEPTOR (Homosapiens) | 5 / 9 | ARG A 611VAL A 543GLY A 609SER A 612LEU A 608 | MOF A 801 (-4.2A)NoneNoneNoneMOF A 801 ( 4.6A) | 1.36A | 6cdqB-4p6wA:0.5 | 6cdqB-4p6wA:13.22 |